Marker Therapeutics (MRKR) Competitors $1.10 -0.04 (-3.51%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.14 +0.03 (+3.18%) As of 05/21/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRKR vs. STTK, HOWL, RENB, ICCC, DTIL, FBRX, ARTV, BLUE, PEPG, and MURAShould you be buying Marker Therapeutics stock or one of its competitors? The main competitors of Marker Therapeutics include Shattuck Labs (STTK), Werewolf Therapeutics (HOWL), Renovaro (RENB), ImmuCell (ICCC), Precision BioSciences (DTIL), Forte Biosciences (FBRX), Artiva Biotherapeutics (ARTV), bluebird bio (BLUE), PepGen (PEPG), and Mural Oncology (MURA). These companies are all part of the "pharmaceutical products" industry. Marker Therapeutics vs. Shattuck Labs Werewolf Therapeutics Renovaro ImmuCell Precision BioSciences Forte Biosciences Artiva Biotherapeutics bluebird bio PepGen Mural Oncology Marker Therapeutics (NASDAQ:MRKR) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends. Is MRKR or STTK more profitable? Marker Therapeutics has a net margin of -179.74% compared to Shattuck Labs' net margin of -1,156.46%. Shattuck Labs' return on equity of -61.92% beat Marker Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Marker Therapeutics-179.74% -89.63% -71.62% Shattuck Labs -1,156.46%-61.92%-54.49% Do analysts rate MRKR or STTK? Marker Therapeutics currently has a consensus price target of $13.17, suggesting a potential upside of 1,096.97%. Shattuck Labs has a consensus price target of $7.50, suggesting a potential upside of 600.93%. Given Marker Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Marker Therapeutics is more favorable than Shattuck Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marker Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Shattuck Labs 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.71 Does the media prefer MRKR or STTK? In the previous week, Marker Therapeutics had 6 more articles in the media than Shattuck Labs. MarketBeat recorded 6 mentions for Marker Therapeutics and 0 mentions for Shattuck Labs. Marker Therapeutics' average media sentiment score of 0.00 equaled Shattuck Labs'average media sentiment score. Company Overall Sentiment Marker Therapeutics Neutral Shattuck Labs Neutral Which has better earnings and valuation, MRKR or STTK? Marker Therapeutics has higher revenue and earnings than Shattuck Labs. Marker Therapeutics is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarker Therapeutics$6.59M1.89-$8.24M-$1.33-0.83Shattuck Labs$4.61M11.13-$87.30M-$1.39-0.77 Does the MarketBeat Community favor MRKR or STTK? Marker Therapeutics received 36 more outperform votes than Shattuck Labs when rated by MarketBeat users. However, 69.64% of users gave Shattuck Labs an outperform vote while only 64.66% of users gave Marker Therapeutics an outperform vote. CompanyUnderperformOutperformMarker TherapeuticsOutperform Votes7564.66% Underperform Votes4135.34% Shattuck LabsOutperform Votes3969.64% Underperform Votes1730.36% Which has more risk and volatility, MRKR or STTK? Marker Therapeutics has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Do insiders & institutionals have more ownership in MRKR or STTK? 22.4% of Marker Therapeutics shares are held by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are held by institutional investors. 14.5% of Marker Therapeutics shares are held by company insiders. Comparatively, 10.5% of Shattuck Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryMarker Therapeutics beats Shattuck Labs on 10 of the 17 factors compared between the two stocks. Get Marker Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRKR vs. The Competition Export to ExcelMetricMarker TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.45M$6.53B$5.38B$8.39BDividend YieldN/A2.64%5.21%4.10%P/E Ratio-0.838.9226.8019.71Price / Sales1.89252.24389.70117.54Price / CashN/A65.8538.2534.62Price / Book0.706.466.804.50Net Income-$8.24M$143.98M$3.23B$248.18M7 Day Performance-2.65%2.03%1.52%0.23%1 Month Performance-7.56%4.11%10.04%12.39%1 Year Performance-72.08%-2.87%16.73%7.07% Marker Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRKRMarker Therapeutics4.1144 of 5 stars$1.10-3.5%$13.17+1,097.0%-72.5%$12.45M$6.59M-0.8360Positive NewsAnalyst RevisionGap UpSTTKShattuck Labs2.5735 of 5 stars$1.05-4.5%$7.50+614.3%-86.1%$50.29M$4.61M-0.69100HOWLWerewolf Therapeutics3.4909 of 5 stars$1.12+0.9%$8.33+644.0%-78.4%$50.26M$1.14M-0.7340Positive NewsRENBRenovaro0.8173 of 5 stars$0.32-1.9%N/A-69.9%$50.12MN/A-0.3420ICCCImmuCell0.1721 of 5 stars$5.48+4.0%N/A+29.0%$49.52M$26.49M-10.9670DTILPrecision BioSciences3.4772 of 5 stars$4.69-0.4%$47.00+902.1%-64.4%$49.48M$68.70M78.18200Earnings ReportAnalyst ForecastFBRXForte Biosciences2.6365 of 5 stars$7.50-4.5%$32.50+333.3%+30,134.7%$49.37MN/A-0.465News CoverageEarnings ReportARTVArtiva Biotherapeutics1.7053 of 5 stars$2.02-0.5%$19.40+860.4%N/A$49.21M$251,000.000.0081BLUEbluebird bio2.7073 of 5 stars$4.98+0.2%$44.60+795.6%-75.1%$48.76M$83.81M-0.13520PEPGPepGen3.1313 of 5 stars$1.49-3.2%$9.67+548.8%-89.6%$48.75MN/A-0.5030Gap UpMURAMural Oncology2.3182 of 5 stars$2.80+5.7%$13.00+364.3%-26.8%$48.35MN/A-0.31119Positive News Related Companies and Tools Related Companies Shattuck Labs Alternatives Werewolf Therapeutics Alternatives Renovaro Alternatives ImmuCell Alternatives Precision BioSciences Alternatives Forte Biosciences Alternatives Artiva Biotherapeutics Alternatives bluebird bio Alternatives PepGen Alternatives Mural Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRKR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRKR Stock Free MRKR Stock Alerts